X·CON 2019 – Healthtech →
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
Managing Director, D.E. Shaw and Co., L.P.
CEO and co-founder of BoostSuite
CEO of Dynamis Corporation
Professor, Michigan State University
Co-Founder and CEO, DNAnexus
Director, Life Sciences Institute, University of Michigan
Nobel Laureate, Professor of Biology, Caltech
October 15, 2019 · New York
October 17, 2019 · Boston
October 22, 2019 · Boston
Exelixis (NASDAQ: EXEL) is a South San Francisco biotechnology company developing drugs for thyroid cancer, prostate cancer, and other conditions.
Sponsored · Whitepaper
Implementing electronic solutions for risk mitigation
Xconomy Insight · Special Report
Insights, wisdom, and inspiration on what it takes
Remain compliant and ensure optimal productivity
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2019, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.